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Abstract: The present work focuses on the physicochemical characterization of selected
mineral-based biomaterials that are frequently used in dental applications. The selected
materials are commercially available as granules from different biological origins: bovine,
porcine, and coralline. Natural and calcined human bone were used for comparison purposes.
Besides a classical rationalization of chemical composition and crystallinity, a major emphasis
was placed on the measurement of various morphostructural properties such as particle size,
porosity, density, and specific surface area. Such properties are crucial to acquiring a full
interpretation of the in vivo performance. The studied samples exhibited distinct particle sizes
(between 200 and 1000 lm) and shapes. Mercury intrusion revealed not only that the total
sample porosity varied considerably (33% for OsteoBiol1, 50% for PepGen P-151, and 60%
for BioOss1) but also that a significant percentage of that porosity corresponded to submicron
pores. Biocoral1 was not analyzed by this technique as it possesses larger pores than those of
the porosimeter upper limit. The density values determined for the calcined samples were close
to the theoretical values of hydroxyapatite. However, the values for the collagenated samples
were lower, in accordance with their lower mineral content. The specific surface areas ranged
from less than 1 m2/g (Biocoral) up to 60 m2/g (BioOss). The chemical and phase composition
of most of the samples, the exception being Biocoral (aragonite), were hydroxyapatite based.
Nonetheless, the samples exhibited different organic material content as a consequence of the
distinct heat treatments that each had received. ' 2009 Wiley Periodicals, Inc. J Biomed Mater Res
Part B: Appl Biomater 92B: 409–419, 2010
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INTRODUCTION
Bone grafts are frequently used in orthopedics, periodon-
tics, and in oral and maxillofacial surgery with effective
clinical outcomes.1–9 This approach has been used routinely
as a treatment for bone regeneration in osseous defects.
Although the greatest success in bone grafting has been
achieved with autogeneous bones, such use is constrained
by limited material supply and donor site morbidity.1,5,6
Numerous biomaterials have been successfully used as
bone substitutes, such as allografts, xenografts, natural and
synthetic calcium-based materials, and a combination of
these.5,7,9 Allografts do not have the drawbacks of auto-
grafts but are less successful in clinical practice. They also
carry several other disadvantages. These include the risk of
disease transmission or infection, difﬁculties in obtaining
and processing, and rapid resorption.1–7 Also, mechanical
strength is partially lost after sterilization.4,9,10 Allogeneic
bone is usually processed as a freeze-dried graft or as a de-
mineralized bone matrix (DBM). The former, while osteo-
condutive, has no osteogenic or osteoinductive capabilities,
being usually placed in conjunction with autogenous
grafts.1,5,6 DBM, on the other hand, retains some osteoin-
ductive properties as a consequence of the demineralization
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process that may expose native matrix proteins, such as
bone morphogenetic proteins (BMPs).11,12
Xenografts have been regarded as promising alternatives
to autografts, given that xenografts represent an unlimited
supply of available material and may reduce morbidity by
eliminating the donor site. Xenogeneic bone, mainly of
bovin origin, was popular in the 1960s but fell into disfavor
because of immunogenicity risks. The reintroduction of
these products, more recently, came after the development
of safer methods to deproteinate bone particles, namely by
heat treatment.13,14 Although most of the xenografts that
are currently used have porcine and bovine origins, because
of their similarity to the human bone regarding chemical
composition (mainly carbonated hydroxyapatite and type I
collagen) and structure,1,5,7,9 the interest in natural coral
exoskeletons has been increasing. This is because natural
coral exoskeletons give reduced risk of disease transmission
and viral contamination compared with the risks posed by
bovine grafts.1,2,5,7,9,15 Coral is composed of calcium car-
bonate in the form of aragonite. It has achieved consider-
able success in bone-graft applications because of its large
porosity and uniform pore size (which can range from 100
to 500 lm) combined with mechanical strength. Although
there are hundreds of genera of coral, only a few meet the
required standards of pore diameter and connectivity.2,7,9,15
Nonetheless, unconverted coral is unsuited for most long-
term implants because of its high dissolution rate, poor lon-
gevity, and poor stability.9,16 High degradation rates have
also been found at low pH values (5.0–6.5), which are nor-
mally associated with infections and inﬂamed tissues. To
overcome this limitation, corals have been converted into
hydroxyapatite (coralline hydroxyapatite) by hydrothermal
exchange or microwave processing, leading to products
with improved resorption rates and better osteointegra-
tion.9,16,17 In this treatment, hydroxyapatite partially repla-
ces aragonite while preserving the porous structure.
However, under certain circumstances, a decrease in struc-
tural strength may be observed.17 This problem can be
reduced through the use of double-conversion techniques
(conversion to coralline apatite followed by sol–gel nano-
coating).9
To avoid the main shortcomings of allografts and xeno-
grafts, products of synthetic origin are increasingly being
developed with the objective of fabricating biomaterials
that mimic the extracellular matrix of bone with not only
respect to the chemical composition but also to structural
and functional properties.18–20 In the recent past, many cal-
cium phosphate-based materials have been employed in the
fabrication of porous scaffolds, whose Ca/P ratios have
been varied to produce compounds ranging from calcium
tetraphosphate (Ca/P 5 2), hydroxyapatite (Ca/P 5 1.67),
tricalcium phosphate (Ca/P 5 1.5), to anhydrous dicalcium
phosphate (Ca/P 5 1).21–23 For similar structures, those
with a low Ca/P ratio resorb more rapidly, giving rise to
unpredictable biodegradation proﬁles and resulting in unde-
sirable loss of mechanical strength.21–25 On the contrary,
those with greater Ca/P ratios degrade more slowly but
may give rise to remnants that can induce inﬂammation. In
addition, lower degradation rates usually result in less new
bone formation around the scaffold. The combination of
different calcium phosphates products can be used as a
strategy to control resorption rates.22–24
However, the chemical composition alone is by no
means the only factor in determining the nature and extent
of scaffold biodegradation. Besides physiological condi-
tions, characteristics such as crystallinity, crystal size, parti-
cle size and size distribution, porosity and surface
roughness have been reported to inﬂuence the biological
performance.24–27
Finally, introducing osteoactive agents in scaffolds, by
loading or by promoting chemical bonding, has been
adopted as a method for stimulating the deposition of bone.
These agents include bone BMPs, cells (osteoblasts, bone
marrow cells),20,28,29 and other bioactive molecules (for
example, P-15 aminoacid sequence).8,30,31
Nevertheless, despite all efforts regarding the develop-
ment of biomaterials to be used as bone grafts, no
available biomaterial is as good as autografts in overall
performance.1–6
The main purpose of this study was the characterization
of a variety of granulate mineral-based biomaterials, which
are both commercially available and frequently used for
dental applications as bone substitutes. These materials
were chosen to encompass materials of different origins
(bovine, porcine, and coralline) and different types (cortical
and cancellous bone and mineral based), including biomi-
metic factors, covering a wide range of products/applica-
tions. Some of these graft materials have been thoroughly
characterized for their physico/chemical properties, using
techniques such as high resolution X-ray diffractometry
(XRD), infrared spectroscopy, and thermogravimetry.32
However, characteristics such as the shape and size (for
those materials that are in a granular form) and morphos-
tructural features, which play an important role on the
materials’ in vivo performance, have not been fully
explored. Beside the chemical composition, it is known
that surface area and topography (mainly pore size) exert a
major inﬂuence over the interaction of osteogenic cells
with the biomaterial surface.27,33 The particle size, for
instance, affects not only the contact area but also the
packing characteristics of the materials, ultimately deter-
mining the macroporosity of the particle ensemble (crucial
for bone regeneration).26,34 Additionally, recent studies
have demonstrated that microporosity can also be used to
accelerate osseointegration.27,35,36
The emphasis of this work concerned the determination
of the physical characteristics, speciﬁcally particle size, po-
rosity, density, and surface area. These parameters were
evaluated using laser spectrometry, image analysis, mercury
porosimetry, gas pycnometry, and gas adsorption. Compari-
son with the data supplied by manufacturers is provided
when available. Sample characterization was complemented
by Fourier transform infrared spectroscopy (FTIR) and
XRD analysis. Comparisons of the properties of the com-
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mercial products with the properties of human bone were
also fully explored. Moreover, as some of the tested materi-
als were anorganic in type and processed using different
thermal treatments, this study also covers both natural and
calcined human bones.
MATERIALS AND METHODS
The biomaterials examined included grafting materials of
different origins: bovine (BioOss1 and PepGen P-151),
porcine (OsteoBiol1), and coralline (Biocoral1). These
samples were characterized as supplied (i.e., with no fur-
ther treatment). BioOss is derived from cancellous bone,
PepGen P-15 from cortical bone, and OsteoBiol is consti-
tuted as a mixture of these two types of bone (80% cancel-
lous and 20% cortical). In addition, PepGen P-15 contains
biomimetic factors (P-15 aminoacid sequence).
Each material was used in a granular form (easier to
accommodate and more quickly resorbed) with the lowest
particle size range available, recommended for application
in the treatment of oral, periodontal, and maxillofacial bone
defects.
BioOss spongiosa granules, produced by Geistlich
Pharma AG (Wolhusen, Switzerland), are reported to be a
natural bone mineral, derived from bovine bone and con-
taining carbonate apatite. The granules are deorganiﬁed by
means of a proprietary extraction process (treatment with
strong alkalis and organic solvents, up to 3008C) that alleg-
edly renders the substrate antigenic and protein free.37 This
material was used as granules of 250–1000 lm.
PepGen P-15 (Dentsply Friadent, Mannheim, Germany),
available as a granulate (250–420 lm), is also an anorganic
bovine material that is composed of pure polycrystalline
hydroxyapatite, created as a result of thermal processing at
11008C, completely removing proteins from bone. After
calcination, a sequence of 15 amino acids of Type I colla-
gen were added to the mineral component.38
OsteoBiol (Tecnoss Dental, Pianezza, Italy), used as
250–1000 lm granules, is a xenograft material of porcine
origin, processed at low temperature (maximum of 1308C)
to completely eliminate any pathogenic elements. The pres-
ervation of the structure and composition of the natural col-
lagen and hydroxyapatite was maintained.39
Biocoral (Inoteb, St. Gonnery, France), a coralline
derived sample, is claimed to be a highly pure ([98%),
bioresorbable, calcium carbonate material in the form of
aragonite, with pore sizes up to 500 lm. According to the
producers, Biocoral presents good hemostatic properties
that are not altered by processing.40 The particle size range
selected for this study was 630–1000 lm (ref MIG 1-1).
As mentioned earlier, the results obtained for these bio-
materials were compared with those of human bone. Thus,
a human cortical bone (gamma-irradiated and freeze-dried
femoral diaphysis, from a male, 39-year-old donor), pro-
vided by the bone bank of Coimbra University Hospital
(HUC Bone and Tissue Bank, Coimbra, Portugal41), was
subsequently segmented and, as described later, subjected
to the same characterization as the commercial samples.
The diaphysis was cross-sectioned into similar segments
(1.5 cm thickness) that were degreased through immersion
in an alcohol series (ethanol at 70% v/v), followed by
washing with distilled water. Afterward, samples were kept
in 30% v/v hydrogen peroxide for 48 h and rinsed again.
The cleaned segments were stored in formaldehyde solution
(4% v/v) at 48C. Before use, the segments were thoroughly
rinsed with distilled water and dried at 508C for 3 days,
being herein designated as ‘‘natural bone.’’
To prepare samples that could be compared to the com-
mercial anorganic samples, some of these segments were
calcined at 6008C in a mufﬂe furnace under normal atmos-
phere, with a heating ramp rate of 108C/min from room
temperature. Samples were maintained at 6008C and were
periodically weighed to constant weight. Then, they were
naturally cooled and kept in a desiccator.
Analytical-grade hydroxyapatite and collagen samples
(purchased from Sigma-Aldrich, Germany) were also used,
namely in the FTIR analysis, to compare their spectra with
those of the bone samples.
Figure 1 illustrates the morphological aspect of the com-
mercial samples that were tested in granular form. Images
were obtained by scanning electron microscopy (SEM),
using a JSM-530 (Jeol Ltd, Tokyo, Japan) microscope
operating at 20 kV. The samples were mounted on double-
coated, carbon-conductive tape and then sputter-coated
with gold.
These materials were ﬁrst characterized for their particle
size. Laser diffraction spectrometry (Coulter LS 130, Beck-
Figure 1. Morphology of the commercial granular samples: (a) Bio-
Oss, (b) PepGen P-15, (c) OsteoBiol, and (d) Biocoral. The SEM
images show different shapes and structural features for various
particulate materials.
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man Coulter Inc., Fullerton, CA) was used.42 Three inde-
pendent measurements were performed for each sample.
The equipment software automatically computes the aver-
age particle size distribution and the corresponding statisti-
cal parameters, with 0.95 conﬁdence level.
Most of the samples contained particles that were larger
than the upper limit of the equipment (900 lm). Hence,
these samples were further analyzed by image analysis
with BH-2 microscope (Olympus) coupled with morphome-
try software CUE-2 also from Olympus (Olympus Corp.,
Lake Success, NY). The number of counted particles was
selected in such a way that a deviation of 5% relative to
the arithmetic average diameter (at a 95% conﬁdence level)
was reached. This counting corresponded to at least 500
particles.
Information concerning the sample porosity and the pore
size distribution was obtained by mercury intrusion43,44
using the Poresizer 9320 (Micromeritics Instrument Corp.,
Norcross, GA) in a pressure range between 0.05 and 2000
atm, corresponding to a range of pore diameters between
400 lm and 0.006 lm, respectively. From the pressure ver-
sus intrusion data, the equipment generates pore size distri-
butions, using the Washburn equation [Eq. (1)].
d ¼ 4c cos h
P
ð1Þ
Based on the cylindrical pore geometry, this expression
relates the pore diameter (d) with the mercury surface ten-
sion (c), the contact angle between mercury and the solid
surface (y), and the applied pressure (P) necessary for mer-
cury to penetrate the sample pores. In the present work, c
was taken as 0.48 N m21 and y as 1408.
The porosity was calculated as the ratio of the intruded
volume and the total sample volume, including all open
voids, as expressed by Eq. (2).
Porosity ¼ VEmpty Spaces
VSolid Material þ VEmpty Spaces ð2Þ
Two samples (2.5 g) were analyzed by this technique.
A third sample was additionally used if the measured po-
rosity values differed by more than 5%. One of the samples
was chosen to illustrate the pore size distribution, presented
in the ‘‘Results’’ section. It should be noted that this tech-
nique uses a relatively large amount of material (thus
ensuring sample representativeness) that cannot be further
used (as it will be mercury contaminated).
The particles’ real density (sample mass/volume of the
solid (excluding empty spaces)) was determined by gas
pycnometry44 (Accupyc 1330 from Micromeritics Instru-
ment Corp.). This measuring method excludes sample inter-
stices and most pores, since the small volume of the gas
molecules (He) enables their penetration in almost all
empty spaces. An exception is given by the sample’s
closed pores, that is, those pores that are not opened to the
surface. The density, measured in this way, provides the
closest value to the solid density of the sample, justifying
the use of the term ‘‘real’’ or ‘‘true’’ density.
At least 10 runs were performed for each sample, and at
least three different samples were analyzed for each mate-
rial. The coefﬁcient of variance was used to compare mean
values, with 5% as signiﬁcance level.
The speciﬁc surface area of the samples were measured
by the nitrogen adsorption technique (ASAP 2000 from Mi-
cromeritics Instrument Corp.), based on BET theory.43,44
The samples analyzed by this method were the same as
those subjected to porosimetry. As mentioned, at least two
independent samples were measured for each material
using the same validation criteria.
FTIR was used to provide information concerning the
chemical composition and the major functional groups.
Spectra were recorded in the range 500–4000 cm21 in
increments of 1.928 cm21, using a Magna FR-750 spec-
trometer (Nicolet,Madison, WI), in the attenuated total
reﬂection (ATR) mode. Each spectrum was collected at
room temperature at a resolution of 4 cm21, and the num-
ber of sample scans was 32.
XRD was used to identify phase and composition fea-
tures and qualitatively evaluate the crystallinity of the
materials. Diffraction data were collected using an X-PERT
diffractometer, (Philips, Amsterdam, Netherlands), operat-
ing in the Bragg-Brentano conﬁguration with Co-Ka radia-
tion (k 51.78897 A˚) at a current of 35 mA and an
accelerating voltage of 40 kV. Spectra were recorded in the
range 108\ 2y\ 708 at a scanning speed of 0.58/min and
step size of 0.028. The obtained X-ray patterns of samples
were compared with the patterns given by hydroxyapatite
and aragonite and the corresponding data from International
Centre for Diffraction Data (ICDD; Powder Diffraction
Files n8 84-1998 and 75-2230).
RESULTS
Particle Size Analysis
Table I contains the particle size parameters (in volume
percentages) of the commercial samples in terms of median
diameter (D50), as well as the particle size range, expressed
by the 10% and 90% percentiles (D10 and D90) and in non-
dimensional form ((D90 2 D10)/D50). Also in Table I are
the size ranges reported by the manufacturers.
The ﬁrst conclusion to be drawn from these results is
that PepGen P-15 has the lowest particle size (approxi-
mately half of the other samples), conﬁrming the observa-
tions of Figure 1. Second, PepGen P-15 and OsteoBiol
correspond to the broader size distributions. In contrast,
Biocoral presents the most homogeneous size distribution.
The experimentally determined size ranges, although not
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coincident with the information supplied by the pro-
ducers37–40 are, nevertheless, relatively close.
Mercury Intrusion
When analyzing a granular material by mercury porosime-
try, two kinds of voids can be detected: those that corre-
spond to the empty spaces between the particles
(commonly designated by ‘‘interstices’’ or ‘‘interparticle’’
spaces) and those that correspond to the voids of the par-
ticles themselves (known as ‘‘pores’’ or ‘‘intraparticle’’
spaces). The results obtained for the granules of BioOss
(Figure 2) show that with increasing pressure, mercury pen-
etrates to the increasingly smaller pores. The cumulative
curve [Figure 2(a)] denotes a small intrusion in pores
between 400 lm (upper limit detection) and 10 lm, fol-
lowed by a plateau between 10 and 0.2 lm where no intru-
sion is detected, and then a signiﬁcant mercury penetration
into pores that are smaller than this value. The initial rise
of the curve corresponds mostly to the ﬁlling of the voids
between the particles (and may also include some of the
largest pores of cancellous bone), whereas the later stage of
rise is related to the pores of the individual particles. The
range of the intraparticle pores is more obvious in Figure
2(b), in which one intense peak whose mode is about 0.03
lm is clearly visible. The smaller peak on the left ([100
lm) corresponds to the intrusion of the mercury in the
interparticle voids. The size of these voids, related to the
way the particles are packed, depends on the particle size
and shape as well as the particle size distribution. However,
the distinction between inter- and intraparticle voids is not
always so apparent. This interpretation aims to elucidate
the kind of information that can be extracted from the pore
size distribution curves and highlight the importance of
always specifying the size range of the measured pores. It
should be stressed that the mercury intrusion technique is
especially suited to the analysis of intraparticle pores, being
not so adequate to the measurement of large voids ([400
lm). Because of this limitation, this technique was not
used with the Biocoral granules, since these possess a large
proportion of very big pores, not completely measurable,
thus leading to a signiﬁcantly underestimated porosity
value.
The intrusion curves (cumulative intruded volume versus
pore diameter) of the three samples that were analyzed in
their granular form are depicted in Figure 3(a). Figure 3(b)
presents the corresponding differential pore size distribu-
tions. Table II summarizes these results in terms of the
total intruded volume, mode of intraparticle pores, total po-
rosity, and intraparticle porosity (taken as the percentage of
the particles internal pores (\1 lm), relative to the total
porosity). Analysis of Table II and Figures 4 and 5 sug-
gests that BioOss has the greatest porosity, being the meas-
ured value in agreement with that reported by the producer
(60%, also obtained by mercury intrusion37). However,
about half of this porosity corresponds to submicron pore
entrances. Smaller porosity values were determined for the
PepGen P-15 and OsteoBiol samples. These also exhibit a
much smaller proportion of submicron pores. An interesting
feature detected for PepGen P-15 is that the mode found
for the intraparticle pores (0.3 lm) is about 10 times larger
than that of the other two samples.












Bio-Ossb 740 510–1030 0.7 250–1000
PepGen P-15c 367 180–558 1.02 250–420
OsteoBiolb 810 455–1260 0.99 250–1000
Biocoralb 980 765–1010 0.25 640–1000
Median diameter (D50), size range expressed in percentiles (D10 and D90) and in nondimensional form [(D90 2 D10)/D50]. The size range reported by the producers is also
presented for comparison. These values show that the PepGen P-15 particles are the smallest in size and that the Biocoral particles have the narrowest size distribution. The size
ranges are relatively close to those reported by the producers.
aD10, D50, and D90: particle diameters corresponding respectively to 10, 50, and 90 % of the cumulative size distribution curve.
b Image analysis.
c Laser diffraction.
Figure 2. Mercury intrusion curves of BioOss measured by mercury
porosimetry: cumulative intruded volume versus pore diameter (a)
and differential-intruded volume versus pore diameter (b). The intru-
sion proﬁles show a small mercury penetration into pores between
400 and 10 lm (interparticle pores) and a signiﬁcant mercury pene-
tration into pores smaller than 0.2 lm (intraparticle pores).
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Table III gives the total intruded volume and porosity
that was measured for the human cortical bone before and
after calcination. The natural human cortical bone (noncal-
cined) presents a low porosity value, as expected, since it
is a compact bone. Subjecting the cortical bone to calcina-
tion at 6008C resulted in an increase in the porosity from
6% to 33%. However, the consequence of this heat treat-
ment was to increase not only the porosity but also the
pore size. As mentioned earlier, the particles of PepGen P-
15, thermally treated at high temperatures (11008C), also
possess intraparticle pores of the same size.
Density
The results from the gas pycnometry study, listed in Table
IV, show that the higher densities were measured for Bio-
Oss and PepGen P-15. These values are quite close to the
theoretical density of the hydroxyapatite crystal
(Ca10(PO4)6(OH)2), reported to be 3.16 g/cm
3.45 The value
obtained for Biocoral coincides with the speciﬁc gravity of
aragonite (2.93),46 a mineral that is composed of calcium
carbonate. These results support the measured values (and
the suitability of the technique). They also give a guide to
the purity of these samples. The lower values correspond,
as expected, to the collagenated samples (OsteoBiol and
natural human bone). The calcination of the natural bone
resulted in an increase in density, bringing the value close
to the theoretical value for hydroxyapatite. The density val-
ues are also consistent with the mineral content of each
sample.
Surface Area
The speciﬁc surface area of each of the samples, in granu-
lar form, were determined by the gas adsorption technique
(BET). The results are listed in Table V. These values
depend on the type of sample (cortical or cancellous bone),
being a consequence of their surface characteristics. The
largest value was achieved for the granules of BioOss,
closely followed by those of OsteoBiol. The remaining
samples exhibit much lower values.
Figure 3. Cumulative (a) and differential (b) intrusion curves of Bio-
Oss, PepGen P-15, and OsteoBiol measured by mercury porosime-
try. BioOss presents the highest intrusion volume whereas
OsteoBiol gives the lowest. Differential curves show that BioOss
exhibits intraparticle pores around 0.03 lm, similar to those of
OsteoBiol but 10 times less than those of PepGen P-15.
TABLE II. Mercury-Intruded Volume, Mode (Most Frequent
Diameter) of Intraparticle Pores, Total Porosity, and Intraparticle














BioOss 0.546 0.03 63.5 51
PepGen P-15 0.308 0.3 49.4 23
OsteoBiol 0.230 0.02 33.1 21
BioOss exhibits the highest porosity. However, about half of this porosity is
derived from submicron pores.
a Corresponding to pores\400 lm.
b Corresponding to pores\1 lm.
Figure 4. FTIR spectra of BioOss, PepGen P-15, calcined human
bone, and hydroxyapatite (from top to bottom). All of the samples
are mainly composed of hydroxyapatite. Additionally, BioOss and
calcined human bone exhibit a small peak at around 1400 cm21,
characteristic of the carbonate group.
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FTIR
The infrared spectra are given in Figures 4 and 5. Figure 4
includes the spectra of BioOss, PepGen P-15, and calcined
human bone as well as the spectrum of hydroxyapatite, the
main constituent of these samples. As expected, they all
show the typical bands originated by this mineral. These
are the more intense phosphate stretching bands observed
at around 1010 cm21 and 560 cm21.32,47,48 Both the Bio-
Oss granules and calcined human bone present, in addition,
a low-intensity double band at 1410–1460 cm21 that corre-
sponds to stretching vibrations of CO3
22, substituting for
phosphate in the apatite lattice. However, this CO3
22 band
is absent in the spectrum of PepGen P-15, certainly as a
result of the high calcination temperature to which this
sample was subjected (11008C).32,49 Human bone samples
that were calcined at 6008C exhibited the carbonate band.
However, the intensity was less than that seen for BioOss,
indicating a lower CO3
22 content. The organic content of
PepGen P-15 was not detected in the FTIR spectrum, prob-
ably because of the small amount present (less than
1.2%).32
The second group of vibrational spectra, depicted in
Figure 5, include the spectra relating to the collagenated
samples, OsteoBiol and natural human bone spectra,
together with the spectrum of Type I collagen for the sake
of comparison. Although both samples have different ori-
gins (porcine and human), their spectra are very similar. As
before, the mineral constituent (hydroxyapatite) gives the
most intense peak at 1010 cm21, as well as the bands
occurring at lower wavenumbers. Above 1300 cm21,
almost all of the bands are exclusively assigned to collagen
vibrations, the exception being those originated by CO3
22 at
1410 and 1460 cm21.32,47
The FTIR spectrum of Biocoral was compared with that
of calcium carbonate. Both spectra were coincident, indi-
cating that Biocoral is composed of pure CaCO3.
XRD
The XRD results can be associated with the chemical com-
position of the respective samples (Figure 6). Thus, diffrac-
tograms from BioOss, PepGen P-15, and calcined human
bone (mineral samples) are compared with the spectrum of
hydroxyapatite [Figure 6(a)]. The spectra of the collagen-
ated samples (OsteoBiol and natural human bone) are
grouped in Figure 6(b).
As expected, the XRD pattern from the mineral samples
correspond to hydroxyapatite,48–50 with coincident peak
positions and relative intensities. However, these materials
present diverse degrees of crystallinity, as indicated in the
Figure 5. FTIR spectra of OsteoBiol, natural human bone, and col-
lagen. As expected, collagen bands are clearly visible in addition to
those of hydroxyapatite.
TABLE III. Mercury-Intruded Volume, Mode of Intraparticle












Natural human bone 0.032 0.02 6.2
Calcined human bone 0.221 0.25 33.1
Heat treatment at 6008C gives rise to a sixfold increase in the porosity and a ten-
fold increase in the intraparticle pore size.
TABLE IV. Real Density (q), as Measured by Helium Pycnometry,
and Mineral Content (Derived from Calcination at 6008C) of the
Different Commercial Biomaterials and of Human Bone (Before
and After Calcination)




Xenograft Bio-Oss 3.21 95.0
PepGen P-15 3.20 98.8
OsteoBiol 2.43 64.6
Biocoral 2.92 96.4
Allograft Natural human bone 2.30 65.0
Calcined human bone 3.10 100.0
The density of anorganic samples is practically coincident to that of hydroxyapa-
tite (3.16). The density of the collagenated samples is consistent with their mineral
content (65%).
a Mean value (CV\ 0.05).
TABLE V. Speciﬁc Surface Area of the Samples in Granular
Form Determined by Gas Adsorption (BET)





The measured values reﬂect the origin of the samples: BioOss (100% cancellous
bone) exhibits the highest value; Osteobiol possesses a lower surface area (80% of
BioOss, in agreement with its composition (80% of cancellous bone)). The value for
PepGen P-15 corresponds to the lowest value of the bone-derived samples, as a con-
sequence of its cortical nature and also of alterations induced by the high-tempera-
ture treatment.
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different peak widths. That is the case of BioOss, whose
diffractogram exhibits broad peaks with a low signal-to-
noise ratio, corresponding to a low-crystallinity material.
On the other hand, the sharp and well-resolved peaks found
in the XRD spectrum of PepGen P-15 indicate a highly
crystalline hydroxyapatite. This is to be expected since this
sample was subjected to high-temperature calcination
(11008C). Human bone that was calcined at a lower tem-
perature (6008C) gives sharper diffraction peaks than those
of BioOss and hydroxyapatite but broader than that of Pep-
Gen P-15.
The diffactograms of OsteoBiol and natural human bone
[Figure 6(b)] represent the dual-phase composition of these
samples. This is because each spectrum presents the more
intense characteristic peaks of hydroxyapatite, superim-
posed on a broad band arising from collagen.
A similarity in the diffraction pattern of calcium carbon-
ate (ICDD File n8 75-2230) and the XRD spectrum of Bio-
coral was observed (data not shown), conﬁrming that this
sample is composed of CaCO3.
DISCUSSION
From the particle-size related data (Table I), it can be con-
cluded that, in general, the size ranges measured for the
materials tested, although different from those reported by
the manufacturers, are similar. It should be noted that most
producers do not specify the technique that was used in the
characterization and that may be responsible for the differ-
ences observed.51 SEM pictures have shown that the sam-
ples exhibit irregular and sharp-edge particles, whose sizes
vary considerably (the median size ranges from about 350–
1000 lm).
The likely inﬂuence of these properties and characteris-
tics on the biological response cannot be easily predicted
as the published studies involve different types of hydroxy-
apatite (natural and synthetic) in different particle size
ranges. This observation applies to both in vitro and in vivo
studies (the latter comprising distinct animal mod-
els).34,52,53 For the ranges of particle size that were tested
in this investigation, it has been reported that smaller par-
ticles (around 300 lm) are the basis of a better perform-
ance.26,34,52,53 However, it should be kept in mind that the
granules under analysis differed not only in their size but
also in other physicochemical properties.
The measured porosity values (Table II) varied from
33% (OsteoBiol) to 63% (BioOss). The majority of the
studies that are published in the literature present only total
porosity values.15,17,19,22 However, it is information con-
cerning the pore size distribution that may be the more rel-
evant to anticipating scaffold performance. A detailed
analysis of the pore size distribution curves that were
obtained by mercury intrusion revealed that, while the
major contribution seems to derive from the 3D array of
the particles (interparticle pores), an important part of po-
rosity results from intraparticle pores (in some cases up to
50%, as found for BioOss). These pores present modes of
0.02 lm for BioOss and OsteoBiol and 0.3 lm for PepGen
P-15.
With respect to the effect of porosity on bone regenera-
tion, there is some controversy in the published literature.
Although it is generally recognized that large pores ([100
lm) enhance new bone formation because they allow
migration and proliferation of osteoblasts and mesenchymal
cells,54 it has also been reported that the presence of micro-
porosity alters the pattern and dynamics of osteointegra-
tion35,36 and might enhance ionic exchange with body
ﬂuids.27 Moreover, it has been shown that nanoporous
structure improve cell adhesion, proliferation, and differen-
tiation.34,55 Nevertheless, pore interconnectivity has been
mentioned as a major beneﬁt.56 In the present case, as sam-
ples are in granular form, interconnectivity is naturally
ensured. Even so, the differences detected, either in the
total porosity or in the pore size can be expected to lead to
distinctive in vivo behavior for the samples.
The comparison between natural and calcined human
bone (Table III) has shown that the calcination process
causes a signiﬁcant increase in the total porosity as well as
Figure 6. Diffractograms of BioOss, PepGen P-15, calcined human
bone, and hydroxyapatite (a) and of OsteoBiol and natural human
bone (b). Samples of the ﬁrst group (a) although solely constituted
of hydroxyapatite exhibit different degrees of crystallinity (different
peak widths); samples of the second group (b) represent the dual-
phase composition [hydroxyapatite (sharp peaks) and collagen
(broad band)].
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the pore size. The calcined cortical bone is nearly ﬁve
times more porous than the natural bone (6 vs. 33%), and
the pore size increased tenfold (from 0.02 to 0.25 lm).
Similar intraparticle pore sizes were detected for PepGen
P-15 particles, which were also subjected to a high-temper-
ature treatment (11008C). This increase in porosity, induced
by temperature, is due to the removal of the organic con-
stituents that are associated with bone. Thus, heat treatment
can be regarded as a convenient way to enhance the poros-
ity of compact bones. However, the calcination temperature
should be controlled because higher temperatures may lead
to signiﬁcant alterations in the structural properties (higher
temperature lead to greater crystallinity and grain size and
to lower porosity and surface area).49,57–59
It should be stressed that mercury porosimetry is unable
to be used to measure pores that are larger than 300–400
lm. Thus, the use of this technique to analyze the Biocoral
granules was infeasible.
The density values that were obtained by gas pycnome-
try (Table IV) are in excellent agreement with the mineral
content of the corresponding samples (obtained at 6008C).
In fact, the density of the anorganic samples (which exhib-
ited mineral contents that were higher than 95%) was found
to be practically identical to that of hydroxyapatite (3.16)
(Bio-Oss, PepGen P-15, and calcined human bone) and to
that of Aragonite (2.19) (Biocoral). As for the collagenated
samples, the results show that both OsteoBiol and natural
human bone resulted in a 65% mineral weight fraction [as
expected from their composition (35% of collagen and
water)], the density values being accordingly lower.
The speciﬁc surface areas, measured by gas adsorption
(Table V), ranged from less than 1 m2/g (Biocoral) up to
60 m2/g (BioOss). These extremely different values are
mainly due not only to the samples’ surface characteristics
but also to the particle size. In fact, the larger values that
were exhibited by the BioOss and OsteoBiol samples are
deﬁnitely associated with the fact that both samples contain
cancellous bone with a rough surface. Curiously, OsteoBiol
contains only 80% of cancellous bone. Its speciﬁc surface
is also about 80% of that of BioOss, which is completely
constituted by cancellous bone. The low values presented
by PepGen P-15 (1.72 m2/g) are not only the result of its
cortical nature but also a consequence of the alterations
that were induced by the heat-treatment conditions
(11008C), which created intraparticle pores that were about
10 times larger than those of BioOss or OsteoBiol (Table
II). The addition of biomimetic factors as well as the least
particle size of its particles certainly compensates, in terms
of bone regeneration, for the reduced speciﬁc surface value.
As a consequence of the coralline nature of Biocoral and
also the large pores of its particles, the low surface area
that was obtained was expected. This limitation will cer-
tainly be balanced by the higher dissolution rate, resulting
from its chemical composition (calcium carbonate).
With the exception of Biocoral (aragonite), the FTIR
spectra and XRD spectra of various materials (including
human bone) were quite similar. The major difference was
derived from the samples being either anorganic or colla-
genated. The latter possesses a lower crystallinity degree
and, thus, correspond to materials that are more prone to
degradation.
These differences in chemical nature and phase compo-
sition, together with those detected in the samples mor-
phostructural properties, are expected to affect the
performance of these materials after in vivo implantation.
CONCLUSIONS
In the present work, four commercial samples of materials
currently used in dentistry were investigated. Regarding
chemical composition, the tested samples can be divided
into two groups: one comprising the hydroxyapatite-based
materials (BioOss, PepGen P-15, and OsteoBiol) and the
other constituted only by Biocoral, a calcium carbonate
(aragonite) material. However, even for those with similar
chemical characteristics, signiﬁcant differences were
detected in terms of particle size, crystallinity, porosity and
pore size distribution, surface area, and mineral content.
Although these morphological characteristics greatly
inﬂuence the in vivo behavior of the samples, they are of-
ten not taken into consideration when the samples’ biologi-
cal performance is evaluated. This may be responsible for
the conﬂicting results frequently found in the literature. It
is believed that the results provided for the materials inves-
tigated will be most useful to fully interpret their clinical
responses.
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